In this special edition of Eagle’s Eye View, Dr. Eagle looks at the most important trials presented at the recent AHA scientific sessions: 1) BROAD, exploring more intensive blood pressure control; 2) ...
The ACC recognizes the hard work and dedication of all Fellows in Training. Take the next step in your career by advancing to an FACC membership – the pinnacle of recognition in cardiology. This ...
SGLT2 inhibitors play an important role in preventing adverse cardiovascular events and improving outcomes in patients with heart failure, diabetes and chronic kidney disease. CardioSmart's updated ...
The following are key points to remember from an international consensus on cardiopulmonary resuscitation (CPR) and emergency cardiovascular care science with treatment recommendations: ...
An expert panel report, one of three in a special series published in JACC: CardioOncology, provides a review of the current evidence for the cardiovascular care of patients before cardiotoxic cancer ...
Showcase your cutting-edge simulator in the ACC.25 Cardio Sim Creator Competition and pave the way for advancements in simulation-based education. Whether you've developed a procedural trainer, a ...
In this week’s View, Dr. Eagle looks at exercise training in patients with hypertrophic cardiomyopathy (HCM). He then reviews the diagnosis and management of Kawasaki Disease. Finally, Dr. Eagle ...
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. An expert panel report published in JACC: CardioOncology ...
New science presented at AHA 2024 and simultaneously published in JACC: Advances provide insights on emerging topics such as the use of artificial intelligence (AI)-enabled left atrial (LA) volumetry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback